CTOs on the Move

Beachbody

www.beachbody.com

 
Beachbody, creator of the nation`s most popular in-home fitness and weight loss solutions including P90X®, Insanity®, and Brazil Butt Lift®, among many others, is a rapidly growing fitness company. Founded in 1998 on the simple principle of helping people achieve their goals and enjoying healthy, fulfilling lives, Beachbody offers an unprecedented opportunity to be a part of a global movement where your work is valued and measurable. Decidedly un-corporate, Beachbody encourages employees, or Dudes as we call them, to bring their unique selves to work, employ a progressive mindset, have fun, and G.S.D. (Get Stuff Done). Your personality and willingness to embrace ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.beachbody.com
  • 3301 Exposition Boulevard Fl 3
    Santa Monica, CA USA 90404
  • Phone: 310.883.9000

Executives

Name Title Contact Details
Irfan Ranmal
Chief Product and Technology Officer Profile
Grant Leathers
Vice President of Technology Operations Profile
Bryan Muehlberger
Chief Information Officer Profile

Funding

Beachbody raised $225M on 06/28/2021

Similar Companies

Breeze Products

Breeze Products is a Largo, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clear!Blue Communications

Clear!Blue Communications is a Birmingham, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Next Day Medical

Next Day Medical is a Savage, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ReNew Life Formulas

ReNew Life Formulas is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Cipla

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla`s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla`s research and development focuses on developing innovative products and drug delivery systems.